Cargando…
A Fungal Sterylglucosidase at the Intersection of Virulence, Host Immunity, and Therapeutic Development
Human fungal infections (mycoses) cause significant morbidity and mortality in high-risk populations. Contemporary antifungal therapies rely heavily on three classes of antifungal drugs, and to date, no fungal vaccine is in clinical use for invasive mycosis. A major gap in knowledge related to funga...
Autor principal: | Cramer, Robert A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9765442/ https://www.ncbi.nlm.nih.gov/pubmed/36255237 http://dx.doi.org/10.1128/mbio.02425-22 |
Ejemplares similares
-
Structure and inhibition of Cryptococcus neoformans sterylglucosidase to develop antifungal agents
por: Pereira de Sa, Nivea, et al.
Publicado: (2021) -
Targeting Sterylglucosidase A to Treat Aspergillus fumigatus Infections
por: Pereira de Sa, Nivea, et al.
Publicado: (2023) -
Role of Sterylglucosidase 1 (Sgl1) on the pathogenicity of Cryptococcus neoformans: potential applications for vaccine development
por: Rella, Antonella, et al.
Publicado: (2015) -
Commentary: Role of Sterylglucosidase 1 (Sgl1) on the pathogenicity of Cryptococcus neoformans: potential applications for vaccine development
por: Martinez, Luis R.
Publicado: (2015) -
Antagonistic fungal enterotoxins intersect at multiple levels with host innate immune defences
por: Zhang, Xing, et al.
Publicado: (2021)